Combination of targeted therapy and chemotherapy prolongs survival in lung cancer, and FDA approves a chemotherapy-releasing device to treat bladder cancer.

by Thomas Celona

Rising prostate cancer rates reignite questions about screening guidelines, and a government report describing the health risks of alcohol may never be published.

by Eric Fitzsimmons

Some people’s cancer treatment may not align with their care goals, and a blood test may detect ovarian cancer at early stages.

by Darlene Dobkowski

A chemotherapy-releasing device helps destroy bladder cancer tumors, and long-distance running linked to increased risk for precancerous polyps.

by Thomas Celona

Some women over 70 may not need chemotherapy for high-risk breast cancer, and an early trial finds a pancreatic cancer vaccine can trigger an immune response.

by Marci A. Landsmann

A targeted therapy offers new treatment for a deadly brain cancer that mainly affects children, and more people in their 40s are getting screened for colorectal cancer.

by Marci A. Landsmann

Most liver cancers can be prevented, and a common type of HPV is linked to skin cancer.

by Eric Fitzsimmons

Doctors often don’t discuss sexual side effects with breast cancer survivors, and cardiac biomarkers may indicate increased risk for certain cancers.

by Thomas Celona

Less than half of people with advanced cancer undergo genomic profiling, and gastrointestinal cancer rates are rising dramatically in younger adults.

by Marci A. Landsmann

Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.

by Eric Fitzsimmons